Revista Farmespaña Industrial Julio-Agosto 2023

Ingeniería y mantenimiento en la industria farmacéutica: garantizar la eficiencia y el cumplimiento La industria farmacéutica es un sector crítico que opera para proteger y mejorar la salud humana. En este sector, las actividades de ingeniería y mantenimiento desempeñan un papel importante para garantizar el funcionamiento ordenado de las instalaciones, la continuidad de la producción, el cumplimiento de la normativa y la producción de medicamentos seguros y de alta calidad. UTKU SAKALI dIRECtOR COMERCIAL dE FISAIR $RbU_UPNPQ[+PQ+ ^NWbQWU^UQWb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ingenierÍa farmacÉutica 102 FARMESPAÑA INDUSTRIAL · JUL/AGO 23